Developing a therapeutic RNA base editing platform
Wave was founded on the idea that controlling backbone stereochemistry has potential to improve chemically modified oligonucleotide therapeutics. We now report a stereopure RNA base editing platform, adding a new modality that can help us deliver transformational therapies for patients .